Scottsdale, Arizona–(Newsfile Corp. – February 28, 2022) – Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following:
The Company is proud to announce entry into a Letter of Intent with sleep fitness innovator – SOMO™. Led by renowned marketing and fitness experts, Lisa Juris & Paul Juris, SOMO™ has developed a patent pending sleep mask, incorporating SOMO™’s Accupressure point, with a unique adjustable retention band, for entry into the soon-to-be $14.5 billion U.S. Sleep Aid market. The global sleep market is currently $432 billion.
Based on the Yin Tang pressure point – which has been clinically shown to induce calm and reduce stress – SOMO™’s innovation has been expertly researched and designed to provide next generation wellness in the burgeoning area of Sleep Fitness™. The Company’s mission statement is to deliver simple and effective solutions for stress relief and sleep fitness, making people healthier and happier.
The parties are negotiating the terms of an equity acquisition by Sibannac, in which the Company would be collaborating with SOMO™ to bring the mask to market as well as develop future wellness products under the SOMO™ brand. Eric Stoll, Sibannac’s Chief Marketing Officer, has already developed the initial branding and will continue that effort for SOMO™ through Sibannac’s Campus Co.
SOMO™ already has a large, pending purchase order, from an international distributer, subject to production of the market-ready sleep mask. The latest prototype will be delivered this week and the final version of the mask is estimated to be ready by mid-April.
Lisa and Paul Juris, co-founders of UrbanCave, Inc., said, “We’re thrilled to add our SOMO™ brand, vision, and expertise to the Sibannac portfolio, and help establish a leadership position in the global health and wellness space. We couldn’t have found a better partner to deliver the highest quality solutions with the utmost integrity.”
David Mersky, CEO of Sibannac, remarked, “The stars are aligning for us now, as we move forward with Lisa and Paul of SOMO™. The opportunity for Sibannac to accelerate its entry into the wellness space with patented, wearable technology, is enormous. The sleep space is exploding and we are bringing the Campus Co. platform to life as Eric Stoll and the SOMO™ team launch the mask and set the stage for future extensions of the brand.”
Cautionary Note Regarding Forward-Looking Statements.
This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Sibannac, Inc. (the “Company”), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in the forward looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.
Media Contact: IR@theCampusCo.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/115026
SILICON SLOPES, Utah--(BUSINESS WIRE)--Domo (Nasdaq: DOMO) announced today that Cenegenics, a leader in the performance…
Vancouver, British Columbia--(Newsfile Corp. - June 20, 2024) - Lophos Holdings Inc. (CSE: MESC) ("Lophos"…
NEW YORK, June 20, 2024 /PRNewswire/ -- Ernst & Young LLP (EY US) today announced…
NASHVILLE, Tenn., June 20, 2024 /PRNewswire/ -- ProviderTrust was recently selected by Modern Healthcare as one…
Why Did You Get into MedTech? Join us at DeviceTalks West to Learn from other…
Gemina Laboratories (OTCQB: GLABF), (CSE: GLAB), (FRA: 817) expands investor reach to U.S. by posting…